Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Happy New Year

posted on Jan 01, 2019 03:53AM

Happy New Year to all of the posters and readers of the RVX and Zenith boards. With a little luck RVX and Zenith will deliver healthy solutions to some serious human issues in 2019. Their delivery of those solutions could make us all very happy and wealthy investors. It's been a long road traveled. The destination is clearly in sight.

Good luck to us all.

tada

5 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply